Although present results provide evidence that HsA reduces the viability of HCC cells via inhibiting Y705 phosphorylation and transactivation of STAT3, signaling molecules responsible for HsA-dependent Y705 dephosphorylation of STAT3 need to be further clarified in the future. This evidence concerns the gene STAT3 and hepatocellular carcinoma.